AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 144 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $200,000 | -36.5% | 2,835 | 0.0% | 0.10% | -28.7% |
| Q2 2015 | $315,000 | +18.0% | 2,835 | 0.0% | 0.14% | +17.2% |
| Q1 2015 | $267,000 | -37.6% | 2,835 | -25.8% | 0.12% | -39.6% |
| Q4 2014 | $428,000 | +82.9% | 3,819 | 0.0% | 0.20% | – |
| Q3 2014 | $234,000 | +33.7% | 3,819 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $175,000 | – | 3,819 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |